that allogeneic recipients reported poorer quality of life. Thus, there is an obvious need for prospective studies of patients undergoing ABMT, including a proper follow-up The main purpose of this study was to evaluate prospectively physical and psychosocial functioning in patients period.
Materials and methods
scales and the global health/QOL scale, item responses were coded so that a higher score represents a better level of functioning. The symptom-oriented scales and items are Sample reversed, a higher score corresponds to a higher level of Patients entered the study between January 1993 and Novsymptoms. ember 1994. Twenty (12 men and eight women) of 24 consecutive patients listed for autologous bone marrow and
The Hospital Anxiety and Depression (HAD) scale: The blood stem cell transplantation were included. Four patients HAD scale measures emotional distress. 20 Seven items conwere excluded: due to insufficient knowledge of the Swedcern depression and seven anxiety (14 items). The four ish language (n = 2), poor mental condition (n = 1) and for response choices reflect an increasing level of emotional organizational reasons (n = 1). The median age was 36 distress. The total score in each scale ranges from 0 (no (range 17-54) years. The underlying hematologic maligsign of distress) to 21 (maximum level of distress). The nancy was Hodgkin's disease (n = 1), non-Hodgkin's lymconstructors of the scale recommend a cut-off level of 8-phoma (n = 5), acute myeloblastic leukemia (n = 5), acute 10 points to identify potential clinical cases of anxiety and lymphoblastic leukemia (n = 4), chronic myeloblastic leudepression (hereafter referred as case). In this study we kemia (n = 3), myeloma (n = 1) and plasmacytoma chose the lower cut-off level for case (у8 points). The (n = 1). All patients received preparatory high-dose chemo-HAD scale has shown satisfactory reliability and validity in therapy, 14 in combination with TBI. [13] [14] [15] screening clinically significant anxiety and depression. [21] [22] [23] [24] The 20 eligible patients were evaluated before ABMT and 14 of these participated in the first follow-up, 2-6
The Sense of Coherence (SOC) scale: The SOC scale meamonths after ABMT. The reasons for not responding to folsures overall capacity to cope with stressful life situations. 8 low-up 1 were death (n = 3), disease-and treatment-related Respondents are requested to mark their answer choice for (n = 1) and refusal (n = 2). Follow-up 1 took place after each item on a seven-point scale with two anchoring discharge for all the participants. In the second follow-up, responses (eg never and very often). The total sum ranges 6 months after follow-up 1, 12 patients participated. The from 13 to 91 points; the higher the score the higher the reasons for not responding to follow-up 2 were disease-and SOC. An example of an item is: 'Has it happened in the treatment-related (n = 1) and refusal (n = 1).
past that you were surprised by the behavior of people whom you thought you knew well'? The SOC scale has been translated into Swedish and has proved to be psychoInstruments metrically sound. 10, 12, 25 Three self-administered questionnaires were used to collect data. Procedure
The research protocol was approved by the Ethics CommitThe EORTC Quality-of-Life Questionnaire (QLQ-C30): This questionnaire was developed by the European tee of the Karolinska Hospital. The patients were invited to participate in the study by one of the authors (LW). Written Organization for Research and Treatment of Cancer Study Group and consists of 30 items. It is a multidimensional, information about the study was given to the patients in which voluntariness was stressed and confidentiality cancer-specific, patient-based and self-administered instrument developed mainly for use in clinical trials of patients guaranteed.
The QLQ-C30, HAD and SOC scales were answered the with cancer. 16 The QLQ-C30 is available in several languages, has been widely used in Europe as well as in the week before the start of high-dose treatment. At the followups QLQ-C30 and HAD scales were applied. The time for USA and shows acceptable reliability and validity. [16] [17] [18] It measures physical function (five items), role function (two follow-up 1 varied due to the health care organization, all but two patients being evaluated between 4 and 6 months items), cognitive function (two items), social function (two items) and emotional function (four items). There are three after ABMT. Follow-up 2 was performed 6 months after follow-up 1. At the follow-ups the questionnaires and an symptom scales (fatigue, pain and nausea/vomiting) and a global health/quality-of-life (QOL) scale (two items). The explanatory letter were sent to patients together with a stamped return envelope. symptoms appetite loss, sleeplessness, dyspnea, constipation and diarrhea and the perceived financial impact of the disease and treatment are measured by single items.
Internal failure in response Three response formats are used: the physical and role function scales are answered with 'yes' or 'no' and the gloTwo patients did not complete all subscales in the EORTC QLQ-C30 and another patient did not answer all of the bal health/QOL scale is answered in a response format ranging from 1 (very poor) to 7 (excellent). All other items items in the SOC scale. have four response choices ranging from 1 to 4 with the alternatives 'not at all', 'a little', 'some' and 'very much'.
Statistical methods Respondents are instructed to report their situation during the previous week.
Most of the scales in the EORTC QLQ-C30 are not normally distributed and therefore non-parametric statistical As recommended by the EORTC study group all the scales and item scores in QLQ-C30, were linearly transformethods were used. To test differences over time, Friedman's two-way analysis of variance was used. Differences med to a 0 to 100 points scale. 19 For the five functional between groups were tested with the Mann-Whitney U test and correlations by using the Spearman rank-order correlation coefficient. Parametric statistical methods were used when evaluating the SOC and HAD scales as they were approximately normally distributed. Differences over time were tested with ANOVA repeated measures, and for comparisons between groups Student's t-test was used. Pearson's correlation coefficient was used. Descriptive data include all patients for whom data were available at each assessment point. In the analysis over time only patients for whom data were available on all three assessments were included. The level of statistical significance was set at P р 0.05.
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Cronbach's alpha coefficient was used to assess internal consistency in all instruments. Coefficients Ͼ0.70 are suggested for group-level comparisons to reflect good internal consistency of an instrument. 26 The alpha level reaches a lower value if the items are few.
Results

Age and gender
Age and gender were not significantly related to the scores on the HAD and SOC scales. There were few significant differences between men and women regarding the scores of the EORTC QLQ-C30. Before ABMT, men (n = 8) had negatively correlated to the subscale cognitive function at follow-up 2 (r = −0.68, P Ͻ 0.05). Thus, the older the patients the worse they rated cognitive function.
C30 symptom scales or in the single items were found between before ABMT, follow-up 1 and follow-up 2.
Comparison between responders and non-responders
For most of the subscales in the EORTC QLQ-C30, Cronbach's alpha coefficients were above 0.70. No one was The patients who participated in the three measurements (n below 0.45. = 12) and those who became non-responders at follow-up (n = 8) formed two groups. The baseline scores were com-
The HAD scale pared and no significant differences were found between the two groups except for the pain subscale (P Ͻ 0.05) and
The mean score, before ABMT, for the subscale anxiety the item regarding financial impact (P Ͻ 0.05) in QLQ- patients (n = 7) before ABMT; five patients at follow-up 1 and four patients at follow-up 2 reached levels indicating The rated median scores in the QLQ-C30 functioning scales were high before ABMT and did not significantly change a clinical case of anxiety. The corresponding number of cases regarding depression was six, and two at each over time (Figure 1 ). However, impairments were recorded in the scales measuring social function on all three follow-up. The anxiety subscale score before ABMT correlated to measurement occasions, as well as in role function and global health/QOL at follow-up 1.
the corresponding value at follow-up 1 (r = 0.59, P Ͻ 0.05) and follow-up 2 (r = 0.56, P = 0.06). The depression subPatients scored low presence of symptoms on all three occasions (Table 1) . No significant differences in the QLQscale score before ABMT correlated significantly to the The possible range was 0-100 points with higher scores representing more perceived symptoms.
corresponding score at follow-up 1 (r = 0.68, p = Ͻ0.01) except for fatigue (r = −0.49, P Ͻ 0.05) and appetite loss (r = −0.57, P Ͻ 0.05) before ABMT. Thus, the weaker the but not at follow-up 2 (r = 0.45, P = Ͼ0.15).
When the patients classified as being cases of anxiety at SOC the more reported fatigue and appetite loss before ABMT. the three assessments were compared to those who were not, a few differences were found in QLQ-C30 functioning
The SOC scale scores did not significantly relate to the anxiety or depression subscale in the HAD scale. scales (Table 2 ). There were no significant differences between the two groups in the QLQ-C30 symptom scales Cronbach's alpha coefficient for the SOC scale was 0.79. and single items except for appetite loss, which was more frequently reported by the cases (P Ͻ 0.01) before ABMT. Cronbach's alpha coefficients for the HAD anxiety subscale Discussion before ABMT and at follow-up 1 and 2 were 0.87, 0.90 and 0.88, respectively. The corresponding figures for the This study found no significant differences over time in the patients' perception of their physical and psychosocial depression subscale were 0.62, 0.67 and 0.86, respectively. functioning before and during the follow-up of 1 year after ABMT. Most patients rated rather good physical and psyThe SOC scale chosocial functioning and few symptoms. However, social function reflecting family life and the possibility of making The mean score of the SOC scale was 67.0 (s.d. 11.9, range 49-86). The values of the correlations between the SOC use of social activities was rated quite low on all the occasions in the present study. BMT survivors' concerns scale and the QLQ-C30 are given in Table 3 . Before ABMT the weaker the SOC the significantly worse the rated role and distress about the effect of their illness on their families have been described in other studies. 5, 27, 28 Furthermore, and social functioning and global health/QOL, and at follow-up 2, the worse the rated physical and social function.
Zabora et al 27 found that because of the great burden and demands of acute illness, treatment and prolonged recovery, The SOC scale scores were not significantly associated with the scores on the EORTC QLQ-C30 symptom scales patients' family and social support networks were at risk Physical and psychosocial function following ABMT L Wettergren et al 501 Table 3 Correlations between the SOC scale and the EORTC QLQ-C30 functioning scales rated before ABMT, at follow-up 1 and at follow-up 2 of dysfunction. In addition, Baker et al 28 found that social be sensitive to detect patients who might benefit from extensive support in the psychosocial field and treat them support was associated with current quality of life indicators and that lack of social support was a predictor of accordingly. Individually structured pre-transplant assessment as well as post-transplant assessments of physical and negative feelings. The first year following ABMT many patients are on sick leave and this has a great impact on psychosocial function and coping capacity may be clinically important to identify vulnerable patients. the role function. Persons whose illness causes impact on their job plans have shown less satisfaction with their qual-
The strength of this study lies in that as far as we know it is the first prospective study of patients undergoing ity of life. 29 In addition, fatigue and dyspnea were more frequently reported symptoms in the present study, which ABMT to follow respondents before and for approximately 1 year after. However, one major limitation is the small may contribute to the decreased social function. Canceroriented fatigue is described as multifactorial and multidisample size, which must be kept in mind when interpreting the results. The results may, furthermore, be biased by the mensional. Biological, psychological, social and personal factors may influence onset, impact, expression, duration fact that several patients got worse and some died during the study. However, those who failed to complete the study and severity of the fatigue experience.
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These results are in accordance with the only previously did not differ in their perceptions before ABMT from those who did not complete the study. It can also be questioned published prospective study evaluating patients during the first year after ABMT, 1 and with the results of studies that whether the instruments used in this study are sufficiently representative to reflect the many aspects that may be affechave been performed on one occasion after ABMT/BMT with varying periods of time since transplantation. 3, 28, 32 ted by ABMT. Other areas such as impaired sexual function and fear of relapse have been identified as important conThese studies confirm that patients usually do remarkably well from a physical point of view as well as in overall cerns in some studies. 34, 35 Furthermore, Ferrell et al 34 interviewed 119 BMT survivors in a qualitative study to investisatisfaction. The areas frequently identified as problematic are stamina, sexual functioning and work. 3, 32, 33 Interestgate how BMT had affected their quality of life and found both negative and positive changes. The reported positive ingly enough, patients with a weaker SOC scored significantly worse on role and social function and global effects on the survivors' quality of life were: 'a second chance was given' meaning an opportunity to return to life, health/QOL, and more fatigue and appetite loss before ABMT than those with a stronger SOC. According to a possibility 'to improve quality of life', 'spirituality had increased' as well as 'appreciation of life'. 34 Antonovsky 8 it may be hypothesized that if patients are used to perceiving their life situation as comprehensible,
In conclusion, in this study patients having malignant blood diseases undergoing ABMT perceive their physical manageable and meaningful they are more likely to perceive their situation as bearable when ill. Although the samand psychosocial functioning as rather good before as well as up to 1 year after the procedure. Impairments were ple is small and more research is needed to verify the results, the findings all show the expected direction as sugreported concerning social function, anxiety and depression as well as fatigue, dyspnea and the financial situation. gested by Antonovsky. In other studies stronger relationships have been found between SOC and indicators of Patients with a weaker SOC scored their physical and psychosocial functioning as worse than those with a stronger psychological and social character. 10, 12, 25 Despite the fact that most patients responding perceived SOC. This may indicate that factors other than the disease and its treatment also have an impact on patients' welloverall good function, a small but significant number reported severe distress and dysfunction after transplant.
being although the results only show a non-significant relationship. Further research is needed to explore healthThe levels of anxiety and depression before ABMT were similar to post-ABMT values. Although the patient sample related quality of life in patients undergoing ABMT. It is suggested that each individual should be evaluated on the is small this may indicate that patients reporting anxiety and depression before ABMT continue to do so after transbasis of the areas of life that she or he considers to be most important for her/his quality of life. plantion. It is suggested that health care providers need to 502 17 Ringdal GI, Ringdal K. Testing the EORTC quality of life
